SETD2-H3K36ME3: an important bridge between the environment and tumors

Area of Science:

• Epigenetics and Cancer Biology
• Molecular Oncology
• Gene Regulation

Background:

• Epigenetic regulation influences tumor initiation, progression, and treatment response.
• The histone methyltransferase SETD2 (SET-domain-containing 2) is vital for epigenetic regulation, impacting transcription and DNA repair.
• SETD2-H3K36me3 serves as a critical link between environmental exposures and tumorigenesis.

Purpose of the Study:

• To review the structure and function of SETD2.
• To elucidate the role of SETD2-H3K36me3 in bridging environmental factors and tumor development.
• To provide insights into the significance of SETD2-H3K36me3 in various cancers for diagnostic and therapeutic advancements.

Main Methods:

• Literature review of SETD2 structure and function.
• Analysis of SETD2-H3K36me3's role in epigenetic regulation.
• Examination of the association between SETD2 mutations and cancer development.

Main Results:

• SETD2 catalyzes histone methylation and interacts with RNA polymerase II.
• SETD2-H3K36me3 is implicated in the development of multiple cancers, including renal, gastric, and lung cancer.
• Mutations in the SETD2 gene are frequently observed in various tumor types.

Conclusions:

• SETD2-H3K36me3 is a key player in tumor suppressor mechanisms.
• SETD2-H3K36me3 is a significant target for clinical diagnosis and cancer therapy.
• Understanding SETD2's function is crucial for advancing cancer treatment strategies.